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ScienceDirectInfectious diseases are the result of molecular cross-talks
between hosts and their pathogens. These cross-talks are in
part mediated by host–pathogen protein–protein interactions
(HP-PPI). HP-PPI play crucial roles in infections, as they may tilt
the balance either in favor of the pathogens’ spread or their
clearance. The identification of host proteins targeted by viral or
bacterial pathogenic proteins necessary for the infection can
provide insights into their underlying molecular mechanisms of
pathogenicity, and potentially even single out pharmacological
intervention targets. Here, we review the available methods to
study HP-PPI, with a focus on recent mass spectrometry based
methods to decipher bacterial–human infectious diseases and
examine their relevance in uncovering host cell rewiring by
pathogens.
Addresses
1 Department of Biology, Institute of Molecular Systems Biology, ETH
Zurich, 8093 Zurich, Switzerland
2 PhD Program in Systems Biology, Life Science Zurich Graduate
School, University of Zurich and ETH Zurich, CH-8093 Zurich,
Switzerland
Corresponding author: Collins, Ben C (collins@imsb.biol.ethz.ch)
Current Opinion in Microbiology 2017, 39:7–15
This review comes from a themed issue on Bacterial systems biology
Edited by Christoph Dehio and Dirk Bumann
For a complete overview see the Issue and the Editorial
Available online 11th August 2017
https://doi.org/10.1016/j.mib.2017.07.005
1369-5274/# 2017 The Authors. Published by Elsevier Ltd. This is an
open access article under the CC BY-NC-ND license (http://creative-
commons.org/licenses/by-nc-nd/4.0/).
Introduction to host–pathogen protein–protein
interactions
Infectious diseases reflect the evolutionary balance be-
tween a host and its pathogen. In order to ensure their
survival and propagation, pathogens have developed nu-
merous intricate tools to subvert their hosts’ defense
mechanisms. Understanding how pathogens actively
rewire host cell defenses is of particular interest in infec-
tious disease research. Ultimately by identifying host-
directed targets for pharmacological intervention, thiswww.sciencedirect.com field of research may contribute to eradicate the public
health burden caused by these agents.
The molecular mechanisms underlying pathogenic rewir-
ing of host cells are widely varied. However, as protein
complexes and their interaction networks into which they
are organized comprise the primary functional modules of
the cell [1], we can predict that the disruption of these host
networks are likely to be a key strategy for manipulation by
pathogens. Re-wiring of the host’s proteome, also known as
pathogenic hijacking, generally includes intervention at
multiple stages of signaling pathways and cellular functions
to ensure the robustness of the virulent intervention [2].
This hijacking by protein–protein interactions may be
carried out by evolutionarily derived partial molecular
mimicry [3], which consists of virulent proteins having
evolved similar structures or motifs to the host proteins
to mediate such HP-PPI. It has further been proposed that
the phenotypic impact of a pathogen is directly proportional
to its ability to rewire the host interactome, and that the
impacts of individual virulent proteins are linked to their
number of interactions with host proteins [4]. Thus,
mapping the host–pathogen protein interactome may pro-
vide valuable insights into the biological functions of viru-
lence factor proteins, highlight interactions critical to the
pathogens’ progression and spread, and improve our overall
understanding on the molecular basis of pathogenicity.
In this review, we aim to summarize the methods avail-
able to characterize HP-PPI, consider their utility by
providing biological insights, and present some outlook
into the how the field may develop going forward. Even
though we are primarily concerned with the possibilities
of characterizing HP-PPI from the perspective of bacte-
rial pathogens, a survey of the literature indicates that
significantly more work has been done for viruses in this
area [5]. As such, an examination of lessons learned from
studies of interactions between viruses and hosts should
also be instructive.
It is well established that due to their minimal genomes
and by being obligate parasites, viruses rely on HP-PPI as
a mean to carry out the pleiotropic functions of their
proteins by hijacking various host protein modules to
either avoid their clearance or enable their spread.
For example, by mapping the Influenza A–human PPI
network, viral proteins were reported to be highly inter-
connected thus forming functional modules, and to
interact with a greater number of host proteins comparedCurrent Opinion in Microbiology 2017, 39:7–15
8 Bacterial systems biologyto the average degree of connectivity in the human inter-
actome [6]. The HP-PPI map further enabled the identi-
fication of multiple molecular mechanisms employed by
the virus to manipulate its host, including how Influenza
proteins intervene in the WNT/b-catenin pathways as a
mean to modulate the host’s interferon production [6].
Unfortunately, the characterization of bacterial HP-PPI
has lagged behind. The reason for this disparity most likely
reflects differences in feasibility. That is, testing all pro-
teins produced by a viral genome for interactions with a
host proteome requires significantly less effort than that for
bacterial genomes due to their increased genomic com-
plexity. Nonetheless there is increasing amount of evi-
dence that bacteria also rewire host cellular pathways via
HP-PPI [2]. Pathogenic bacteria can interact with their
host’s proteome by three main mechanisms. First, bacterial
membrane proteins are an obvious interaction point, as
they are located at the physical interface between both
organisms. Secondly, bacteria might secrete effector pro-
teins (also known as virulence factors) into the host cell
where they can interact with the host proteome. Secreted
effector proteins are of particular interest as they are
frequently required for full virulence [7]. Additionally,
some bacterial pathogens such as certain Shigella dysenteriae
or Escherichia coli strains express Shiga toxins generally
during their lytic cycle [8] or release these toxins through
Outer Membrane Vesicles during their growth phase [9],
leading to the inhibition of protein synthesis or activation
of the apoptotic pathways of their host cells. As the number
of bacterial host–pathogen interaction studies increases,
they demonstrate that while bacteria generally do not rely
on host cell machinery for the purpose of replication as
directly as viruses do, they do seem to disrupt the immune
response [10] and interact preferentially with the hosts’
cytoskeleton as a mean of motility, invasion of the host
tissues [11] and escape of phagocytic cells [12]. For in-
stance, Mycobacterium tuberculosis (Mtb), an intracellular
parasite, is known to modulate the host’s immune response
and prevent its bacterial clearance by suppression of
autophagy. Recent work has shown that a secreted Mtb
factor, PE_PGRS47, locates in the host’s cytosol and
inhibits the Major Histocompatibility Complex II mediat-
ed antigen presentation, thereby partially suppressing the
autophagy of the Mtb containing macrophages in chronic
stages of infections [13]. By mapping such host interactors,
HP-PPI studies could hint us towards the molecular
mechanisms behind certain virulence factors like this
PE-PGRS47. In this review, we will describe the available
methodologies to achieve such goals and discuss their
impact on mechanistic understanding or host cell rewiring.
Protein–Protein Interactions detection
methods
Yeast2Hybrid
Historically first, the Yeast Two Hybrid (Y2H) method
has been extensively used to detect direct physicalCurrent Opinion in Microbiology 2017, 39:7–15 interactions between two ectopically expressed tagged
proteins in yeasts [14]. Although this method generates
direct binary interaction datasets at high throughput, the
need for exhaustive screens hampers its feasibility, and its
technical challenges such as the non-physiological ex-
pression system provokes high rates of false negatives
[15]. Nonetheless, many studies in the field of infectious
diseases have successfully employed Y2H screens to
investigate (near) genome-wide virus–host interactions
[16–23], to compare homologous viral proteins from vari-
ous strains [24,25], or to systematically map bacterial
effector proteins–host interactions [26,27,28–31] (see
Supplementary Table 1). In the context of M. tuberculosis
infections, a Y2H screen along with functional valida-
tions, enabled the discovery of a molecular mechanism by
which an effector protein, named EsxH, targets the
Endosomal Sorting Complexes Required for Transport
(ESCRT) necessary for endosomal membrane trafficking,
thereby impairing the phagosomal maturation and fusion
with the lysosomes [28].
Affinity purification-mass spectrometry and immuno
purification-mass spectrometry
In the past two decades, improvements of mass spectrom-
etry (MS) based proteomics in combination with affinity
purification (AP) methods have enabled the systematic
detection of PPI in near physiological environments [32]
(see Figure 1). Most commonly, it consists of fusing an
affinity epitope tag to a bait protein, followed by a single
or double biochemical affinity-purification or immuno-
purification (IP) steps in native lysis conditions. The
purified bait, along with the non-covalently bound inter-
acting proteins or macromolecular protein complexes
(preys), are then identified and quantified via standard
bottom up proteomics. To filter out non-specific interac-
tions, this strategy relies on quantitative comparisons with
control purifications.
In the field of infectious diseases, AP-MS is commonly
applied to systematically map the interactome of indi-
vidual virulent proteins ectopically expressed in the
host’s environment [24,33,34,35,36–44], to monitor
single virulent proteins [45] or upon infection [46] (see
Supplementary Table 1). A related strategy uses immo-
bilized recombinant bacterial effectors on beads [47]
combined with AP-MS from their incubation with human
plasma.
Although expressing single virulent genes in host envir-
onments is informative, it is believed that during the
course of infections, the host–pathogen interactomes
undergo infection stage-dependent dynamic changes
[48], influenced by the hosts’ responses and by the other
co-expressed virulent proteins. Thus, some groups have
generated replication-competent, epitope tagged viruses
which enabled the spatio-temporal monitoring of empiri-
cal and quantitative changes upon viral infectious of hostwww.sciencedirect.com
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10 Bacterial systems biologycells, including for Alphavirus Sindbis [48] and most
recently HIV infected human cells [49]. On the basis
of similar principles, Mousnier et al. and subsequently So
EC et al. respectively developed and applied a double
purification based method coupled to mass spectrometry
to enable the identification of HP-PPI of bacterial effec-
tor proteins in host cells upon infections of Legionella
pneumophila. This study, amongst others findings, de-
scribed how three effector proteins may target up to
25 Rab GTPases individually during the course of infec-
tions [50,51] (see Supplementary Table 1).
Proximity dependent labeling-mass spectrometry
BioID has recently emerged as a new possibility to detect
transient and weaker PPI [52] complementary to AP-MS
[53]. This method relies on the fusion of a mutated
promiscuous biotin ligase BirA* to the bait protein. Dur-
ing an incubation with high biotin concentrations, neigh-
boring proteins to the fused BirA*-bait protein undergo
proximity dependent biotinylation reactions. Biotin-
conjugated proteins, potential direct or indirect interac-
tors of the bait, can then be affinity purified using
streptavidin-coated affinity matrices and quantified by
mass spectrometry (see Figure 1). Because the identifi-
cation of interactions does not depend on the native
purification conditions, weak, transient and insoluble
interactions such as for membrane proteins can be readily
identified [52]. BioID has been applied as a mean to
obtain comprehensive interactome information of select-
ed bacterial proteins [54] belonging to the human path-
ogen, Chlamydia psittaci (see Supplementary Table 1). A
variation of this proximity labeling strategy, called APEX,
enables much faster reaction times (30 s), and opens
up the possibility of time-resolved proximity measure-
ments [55].
Chemical crosslinking-mass spectrometry
Chemical crosslinking coupled to mass spectrometry
(XL-MS) consists of chemically crosslinking proximal
reactive side chains of exposed specific amino acids from
native proteins in monomeric states or in protein com-
plexes, followed by an MS based, bottom up approach to
identify the crosslinked peptides and infer their proteins.
XL-MS thus yields fixed distance restraints between
bound residues, suggesting direct physical intra-protein
or inter-protein interactions between crosslinked pep-
tides belonging to the same or distinct proteins respec-
tively [56] (see Figure 1). Chemical crosslinking reactions
can be performed on purified protein samples [57] using(Figure 1 Legend) Mass spectrometry based methods for host–pathogen p
infections. AP/IP-MS from epitope tagged bacterial effector proteins (a) pos
HP-PPI. Along with other hypotheses driven methods such as ectopic expre
can lead to near comprehensive identifications of HP-PPI. However, becaus
limited by the number of proteins that can be cloned and expressed in the 
Correlation Profiles — MS (3) methods, although less sensitive, do not requi
novo discovery of physiological and endogenous HP-PPI directly from infec
Current Opinion in Microbiology 2017, 39:7–15 GFP epitope tags [58], on cell lysates [59] or on living
cells such as on the pathogen Pseudomonas aeruginosa [60].
Although having gained popularity in recent years to
study the topology of protein networks, decipher the
architecture of macromolecular complexes, and provide
insights into domain-resolution protein interactions, XL-
MS has not yet been widely applied to study HP inter-
actions due to its challenging utilization. One exception is
the unbiased study of live human epithelial H292 cells
infected with A. baumannii which led to the identification
of 46 HP-PPI [61] (see Supplementary Table 1).
Protein microarray based technologies
Membrane proteins play pivotal roles in infections by
mediating host–pathogen recognition, docking, adhesion,
invasion and secretion. Regrettably, their lack of solubili-
ty and their necessity of remaining in lipid-rich environ-
ment highly impair their interactome mapping via
conventional methods such as AP-MS. To overcome
these challenges, Glick et al. introduced a screening
method for HP interactions, adequate for transmembrane
proteins [62] named the human Membrane Protein
Array (MPA). Similarly, several studies have developed
and applied Protein Micro Array technologies [63] in-
cluding Nucleic Acid Programmable [64] or AVEXIS
(AVidity-based Extracellular Interaction Screen) [65,66]
to study soluble and transmembrane HP interactions (see
Supplementary Table 1).
Discussion
There are a variety of methods available for detecting
PPI, where each of them may be applied to answer
different questions and come with their own advantages
or disadvantages (see Table 1). Many methods have been
successfully applied to the HP-PPI field and lead to the
discovery of important biological insights. For instance,
although human host interactors of viruses and bacteria
range across all biological functions, common or pathogen
specific themes can be observed within pathogenic
groups by meta-analysis of HP-PPI studies. First, viral
proteins and to a lesser extent secreted bacterial effector
proteins [30], are both more likely to interact with host
hub proteins (highly connected proteins in the host
network) [16,17,21] and bottleneck proteins (central pro-
teins to many signaling pathways) [10,31,67] for an in-
creased efficiency in altering host cellular processes.
Secondly, by performing gene ontology enrichment
analysis on the host targets, viral pathogens seems to
unavoidably disturb cellular processes as they rely onrotein–protein interactions detections in the context of bacterial
t infections of their host cells enables the identification of physiological
ssions of tagged bacterial proteins in the host environment (b,c), they
e they rely on the prior tagging of the proteins of interest, they are
relevant cellular systems. Chemical Crosslinking — MS (2) and Protein
re prior knowledge and tagging of bacterial proteins and thus allow de
ted cells (2 and 3).
www.sciencedirect.com
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Table 1
An overview of the main advantages and disadvantages for the commonly used HP-PPI detection methods. Although Y2H and protein
microarray based technologies are high throughput and could theoretically test any gene combinations, they are based on non-
physiological experimental conditions and may identify only binary PPI. Techniques such as AP-MS and proximity-dependent labeling
coupled to MS, on the other hand, generate physiologically relevant PPI with information about the Post Translational Information (PTM)
states of the identified prey proteins and can detect entire protein complexes. Similarly, but in an unbiased manner as it may detect
proteome-wide PPI without the need of prior genetic engineering of the pathogens or host cells, PCP-MS and XL-MS on infected cells
may detect de novo HP-PPI in physiologically relevant conditions. Furthermore, mass spectrometry based methods may be coupled to
quantitative proteomics to monitor in a time course-compatible manner, qualitative and quantitative changes of proteins complexes
between biological conditions. Unfortunately, the sensitivity of proteome-wide HP-PPI like PCP-MS and XL-MS remain their largest
drawback and would probably never gain the same sensitivity as for more targeted methods like AP-MS to study specific protein
complexes. Lastly, although XL-MS may be applied on purified protein complexes and provide valuable information their structural
arrangements and topologies, it requires high amounts of purified protein complexes and the data analysis remains challenging
Yeast 2 Hybrid (Y2H)
Advantages High throughput
 existing human and pathogen ORFeome collections  universality — any cDNA from any protein is testable
Dis-advantages Need for exhaustive screens  non-physiological experimental conditions  detects only binary interactions  no PTM
information
Affinity purification-mass spectrometry (AP-MS)
Advantages High throughput  sensitive  detects entire protein complexes  PTM sensitive  when using antibodies against the bait of
interest, can be applied from infected tissues directly
Dis-advantages Need for transgenic cell lines  needs additional experimental data to distinguish direct from indirect interactors  the
identification of PPI depends on the biochemical extraction conditions
Chemical crosslinking-mass spectrometry (XL-MS) on:
Purified protein complexes Infected cells or infected cell lysates
Advantages Provides information on interacting protein domains  residue to residue resolution
Information on the topology and structural
arrangement of protein complexes
Whole-proteome  adequate for soluble and
membrane proteins  can be applied on infected
tissues directly
Dis-advantages For predefined and purified protein complexes only
 need for large amounts of purified protein
complexes  complex data acquisition and analysis
Low sensitivity/resolution  complex data
acquisition and analysis
Proximity dependent labeling strategies-mass spectrometry
BioID Ascorbate Peroxidase-based Proximity Tagging (APEX)
Advantages Sensitive  appropriate for weak and transient interactions  adequate for resolving the spatial organizations of
the tagged proteins  identification of PPI does not depend on the biochemical extraction conditions
Suitable for soluble and transmembrane proteins Fast reaction times, amenable for time course
experiments for temporal resolutions
Dis-advantages Long reaction times, not suitable for time
course experiments
So far applicable to membrane proteins only
Hard to distinguish direct from indirect/proximal interactors
Protein microarray based technologies
Nucleic Acid Programmable Protein Array (NAPPA) Human Membrane Protein Array (hMPA)
Advantages High throughput  universality — any cDNA from
any protein is testable  no need for protein
purification compared to classical protein
microarrays  gene size does not seem to affect its
final intensity
High throughput  physiological for membrane
proteins  recognition against the entire pathogen 
naturally occurring PTM on the surface of tested
pathogen
Dis-advantages Non-physiological  only binary interactions are
detected  no PTM information
For membrane proteins only  no PTM on the
expressed protein
Protein Correlation Profiling (PCP)
Advantages Whole proteome studies  unbiased  stoichiometric and quantitative information readily available
Dis-advantages Dynamic range of protein abundances between host and pathogen might be too important  low sensitivity  hard to detect
kiss and run interactions
www.sciencedirect.com Current Opinion in Microbiology 2017, 39:7–15
12 Bacterial systems biologythe transcriptional machinery, whereas bacteria tend to
mesh with the immune response to prevent their clear-
ance [10]. Thirdly, the manipulation of the host ubiquitin
pathways by viruses [68] and bacterial effector proteins
[69] is a recurrent finding. By controlling protein degra-
dation and cell signaling, ubiquitination is a critical regu-
lator of various cellular processes such as inflammatory
responses, vesicular trafficking and cell cycle, altogether
making it an ideal target to hijack for bacterial and viral
pathogenicity. Indeed, there is increasing amounts of
evidence that numerous human bacterial pathogens hi-
jack and modulate the host ubiquitin processes utilizing
molecular mimicry to impair the hosts’ defense systems,
including the ubiquitin-dependent autophagy, the NF-
kB and the inflammatory signaling pathways [70,71].
Numerous approaches could be employed to further
improve the quality and completeness of HP-PPI net-
works. These include combining orthogonal PPI detec-
tion methods [53,72,73], considering strain specific
variation in dependence on the host cellular modules
[74], to acknowledge the genetic diversity of both hosts
and pathogens [75] and to beware of host cell-type
dependent HP-PPI [33]. The use of more physiological
systems for studying these interactions is also a proximal
goal, such as adopting more disease relevant cells or
transgenic animal models for the ectopic expression of
tagged pathogenic proteins. Likewise, employing infec-
tion systems where the virulent proteins are tagged within
the pathogen could provide dynamic and more physio-
logical maps of the HP-PPI.
The systematic study of bacterial–host interactions brings
additional challenges. The first is to identify all secreted
proteins upon infection, where in silico predictions and
experimental findings do not always corroborate [76]. To
help the identification of virulence factors from mem-
brane-contained intracellular bacterial pathogens, one
could consider purifying intact pathogen-containing com-
partments or vacuoles, and characterizing their proteome
by mass-spectrometry to find new virulence factors that
associate with the host membranes [77]. Secondly, due to
their increased genomic complexity compared to viruses,
the generation of transgenic cell lines to ectopically
express each putative secreted protein would be highly
time-consuming. Thirdly, bacterial systems generally
lack adequate genetic tools preventing endogenous tag-
ging of their secreted proteins. Thusly, we hypothesize
that more global approaches for bacterial–host PPI detec-
tion may be useful. In the last years, numerous groups
have been working towards developing methods which
do not require genetically engineered cells to systemati-
cally identify in an unbiased manner endogenous protein
complexes in physiological samples by correlating protein
profiles (PCP-MS) across various biochemical separations
or chromatographic techniques [78,79]. Not only does this
mass-spectrometry based approach yields lists of putativeCurrent Opinion in Microbiology 2017, 39:7–15 protein complexes, but it also reports stoichiometric and
quantitative information for the identified components.
Unfortunately, despite tremendous improvements in the
field, the sensitivity remains the limiting factor. It is
especially problematic in infectious diseases, where the
dynamic ranges in terms of protein abundances from
pathogenic organisms are generally several orders of
magnitude lower than those of the host proteome [80].
In any case, regardless of which methods were employed,
it is imperative to validate and functionally characterize
the discovered HP-PPI to understand how they impact
the course of infections. To do so, interaction studies can
be coupled to endogenous host interaction maps [81,82]
or to functional genomic screens to measure the fitness
cost upon disruptions of either pathogenic or host molec-
ular components [21], as was done for the HCV inter-
actome [33]. By measuring sets of phenotypes such as
pathogenic replication or host cell death, functional stud-
ies have the benefice of being able to simultaneously
identify the positive, negative or neutral impact on the
infection of targeted bacterial [83] or host factors [74,84].
Altogether, interaction studies, biochemical characteriza-
tions and functional screens may not only identify host–
pathogen interactions, but also inform us on their pheno-
typic impacts and their molecular mechanisms for bacte-
rial or viral pathogenicity.
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